These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 30170622)

  • 1. Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases.
    Garcia CA; El-Ali A; Rath TJ; Contis LC; Gorantla V; Drappatz J; Davar D
    J Immunother Cancer; 2018 Aug; 6(1):83. PubMed ID: 30170622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory demyelinating polyneuropathy versus leptomeningeal disease following Ipilimumab.
    Cafuir L; Lawson D; Desai N; Kesner V; Voloschin A
    J Immunother Cancer; 2018 Jan; 6(1):11. PubMed ID: 29382383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy.
    Shiuan E; Beckermann KE; Ozgun A; Kelly C; McKean M; McQuade J; Thompson MA; Puzanov I; Greer JP; Rapisuwon S; Postow M; Davies MA; Eroglu Z; Johnson D
    J Immunother Cancer; 2017; 5():8. PubMed ID: 28239462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis.
    Larkin J; Chmielowski B; Lao CD; Hodi FS; Sharfman W; Weber J; Suijkerbuijk KPM; Azevedo S; Li H; Reshef D; Avila A; Reardon DA
    Oncologist; 2017 Jun; 22(6):709-718. PubMed ID: 28495807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab.
    Menzies AM; Johnson DB; Ramanujam S; Atkinson VG; Wong ANM; Park JJ; McQuade JL; Shoushtari AN; Tsai KK; Eroglu Z; Klein O; Hassel JC; Sosman JA; Guminski A; Sullivan RJ; Ribas A; Carlino MS; Davies MA; Sandhu SK; Long GV
    Ann Oncol; 2017 Feb; 28(2):368-376. PubMed ID: 27687304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed onset of neurosarcoidosis after concurrent ipilimumab/nivolumab therapy.
    Tan I; Malinzak M; Salama AKS
    J Immunother Cancer; 2018 Jul; 6(1):77. PubMed ID: 30064495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literature.
    Spain L; Walls G; Julve M; O'Meara K; Schmid T; Kalaitzaki E; Turajlic S; Gore M; Rees J; Larkin J
    Ann Oncol; 2017 Feb; 28(2):377-385. PubMed ID: 28426103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seronegative autoimmune autonomic ganglionopathy from dual immune checkpoint inhibition in a patient with metastatic melanoma.
    Gao CA; Weber UM; Peixoto AJ; Weiss SA
    J Immunother Cancer; 2019 Oct; 7(1):262. PubMed ID: 31623673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy-associated autoimmune hemolytic anemia.
    Khan U; Ali F; Khurram MS; Zaka A; Hadid T
    J Immunother Cancer; 2017; 5():15. PubMed ID: 28239468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute visual loss after ipilimumab treatment for metastatic melanoma.
    Wilson MA; Guld K; Galetta S; Walsh RD; Kharlip J; Tamhankar M; McGettigan S; Schuchter LM; Fecher LA
    J Immunother Cancer; 2016; 4():66. PubMed ID: 27777775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune Bell's Palsy Following Immunotherapy For Metastatic Melanoma: A Report of 2 Cases.
    Zieman D; Frankel AE
    J Immunother; 2019 Oct; 42(8):318-320. PubMed ID: 31318723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Mayo Clinic Experience With the Neurological Complications of the CTLA-4 Inhibitor Ipilimumab.
    Ruff MW; Mauermann ML
    Neurologist; 2018 May; 23(3):98-99. PubMed ID: 29722744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ipilimumab-induced necrotic myelopathy in a patient with metastatic melanoma: A case report and review of literature.
    Abdallah AO; Herlopian A; Ravilla R; Bansal M; Chandra-Reddy S; Mahmoud F; Ong S; Gokden M; Hutchins L
    J Oncol Pharm Pract; 2016 Jun; 22(3):537-42. PubMed ID: 25712627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune polyradiculitis due to combination immunotherapy with ipilimumab and nivolumab for the treatment of metastatic melanoma.
    Lasocki A; Smith K
    J Clin Neurosci; 2020 Apr; 74():240-241. PubMed ID: 31983645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma.
    Liao B; Shroff S; Kamiya-Matsuoka C; Tummala S
    Neuro Oncol; 2014 Apr; 16(4):589-93. PubMed ID: 24482447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remote-onset alopecia areata attributed to ipilimumab.
    Pearson DR; Lewis K; Alkousakis T
    Cutis; 2019 Dec; 104(6):E25-E27. PubMed ID: 31939941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ipilimumab induced digital vasculitis.
    Padda A; Schiopu E; Sovich J; Ma V; Alva A; Fecher L
    J Immunother Cancer; 2018 Feb; 6(1):12. PubMed ID: 29433584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case of Acute Exacerbation of Chronic Adrenal Insufficiency Due to Ipilimumab Treatment for Advanced Melanoma.
    Sakaguchi C; Yano S; Ashida K; Wada N; Ohe K; Nagata H; Matsuda Y; Sakamoto S; Sakamoto R; Ohnaka K; Uchi H; Furue M; Nomura M; Ogawa Y
    Am J Case Rep; 2019 Jan; 20():106-110. PubMed ID: 30679413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain-Barré Syndrome Triggered by Immune Checkpoint Inhibitors: A Case Report and Literature Review.
    Supakornnumporn S; Katirji B
    J Clin Neuromuscul Dis; 2017 Dec; 19(2):80-83. PubMed ID: 29189553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of immunotherapy-induced immune-related adverse events.
    Kartolo A; Sattar J; Sahai V; Baetz T; Lakoff JM
    Curr Oncol; 2018 Oct; 25(5):e403-e410. PubMed ID: 30464691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.